Travoprost Ophthalmic Solution
Product Images NDC 42571-130

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 42571-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travoprost Figa

An instructional illustration diagram of an ophthalmic solution bottle showing its parts. The diagram labels the cap, the bottle, and the tear off tamper evident ring around the neck of the bottle, identified as Fig. A.*

FDA Label Image

Travoprost Figb

An instructional diagram showing a hand holding a small bottle, likely an ophthalmic solution bottle, with the other hand removing or adjusting the protective seal around the cap. The figure is labeled 'Fig. B.'*

FDA Label Image

Travoprost Figc

An instructional illustration showing hands holding an ophthalmic solution bottle and twisting the cap to open or close it, likely part of usage or administration instructions for Travoprost Ophthalmic Solution.*

FDA Label Image

Travoprost Lbla

Label for Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL) in 2.5 mL solution form. The label indicates it is an ionic buffered solution for ophthalmic use only, manufactured by Micro Labs Limited, India, and for Micro Labs USA, Inc. The label includes storage instructions at 2°-25°C and states that the usual dosage is in the insert.*

FDA Label Image

Travoprost Lblb

Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL), ionic buffered solution, for ophthalmic use only. The label shows a 5 mL quantity, prescription only, manufactured by Micro Labs Limited in India, and for Micro Labs USA, Inc. Storage instructions and dosage reference to insert are also included.*

FDA Label Image

Structure (Travoproststructure)

Chemical structure of Travoprost, the active ingredient in Travoprost Ophthalmic Solution 0.04 mg/mL. The diagram shows the molecular layout with functional groups and stereochemistry depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.